Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Dana-Farber Cancer Institute
N

Relapse Refractory Myeloma and Novel Treatments

By Dana-Farber Cancer Institute FEATURING Noopur S. Raje
By Dana-Farber Cancer Institute FEATURING Noopur S. Raje
246 views
June 22, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

15:11
Incyte

The Importance of Intervention at the First Signs of Initial Systemi…

Feat. P. Chaudhary

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Myeloma
07:41

ASH 2024 Insights: Effectiveness of Immunoglobulin Replacement on Hy…

2024 ASH Annual Meeting Insights Hub

E. O'Donnell

63 views
10:37

ASH 2024 Insights: Cilta-Cel CAR-T in High-Risk SMM - Results From C…

2024 ASH Annual Meeting Insights Hub

O. Nadeem

58 views
15:00

FDA Approval of Isatuximab in 1L MM: Perspectives for Practice

Dana-Farber Cancer Institute

P. Richardson

1.0K views
19:24

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - Incorpo…

Insights from 2023 ASH Annual Meeting

P. Richardson

762 views
15:13

ASH 2023 Insights: "Mezigdomide + Dex + Dara or Elo in Pts With R/R …

Insights from 2023 ASH Annual Meeting

P. Richardson

140 views
15:49

SOHO 2023 DEBATE: Early HDM-aSCT in MM Is No Longer the SoC

SOHO 2023 Eleventh Annual Meeting

C. Mo

159 views
16:25

SOHO 2023: Treatment of the Frail MM Patients - Personalized Care

SOHO 2023 Eleventh Annual Meeting

B. O'Donnell

143 views
09:52

IMS 2023 Insights: "Epigenetic Regulation of CD38/48 by KDM6A and NK…

Insights from 2023 IMS Annual Meeting

J. Liu

53 views
11:35

ASCO® 2023 Insights: "Updated Phase I Study Results of PHE885, a T-C…

Insights from 2023 ASCO® Annual Meeting

A. Sperling

237 views
32:03

Emerging and Current Treatment of MM: What Should We Know and What S…

Indy Hematology Review

K. Anderson

653 views
41:46

Early Detection and Interception in Myeloma: The PROMISE Study

Yale Cancer Center

I. Ghobrial

141 views
36:59

Updates on Managing Bone Disease in Multiple Myeloma

Dana-Farber Cancer Institute

M. Hartley-Brown

70 views
23:11

Bispecific Antibodies in Multiple Myeloma

Dana-Farber Cancer Institute

O. Nadeem

201 views
54:12

Symptom Management in Multiple Myeloma

Dana-Farber Cancer Institute

S. Midha

145 views
23:40

Update on CAR T-Cells in Multiple Myeloma

Dana-Farber Cancer Institute

A. Sperling

124 views
34:40

Updates on AL Amyloidosis Treatment: What is New in 2023

Dana-Farber Cancer Institute

G. Bianchi

294 views
48:46

The Ongoing Evolution of Systemic Therapy for ND Multiple Myeloma

Dana-Farber Cancer Institute

C. Mo

26 views
47:04

Future Directions for Novel & Next Gen Therapy in the Management of …

Dana-Farber Cancer Institute

P. Richardson

316 views
20:28

The PROMISE of Early Detection and Interception in Myeloma

Dana-Farber Cancer Institute

I. Ghobrial

214 views
44:49

Recent Updates in Multiple Myeloma

Dana-Farber Cancer Institute

K. Anderson

746 views
26:24

Myeloma 101: Diagnosis, Prognosis & Risk

Dana-Farber Cancer Institute

N. Munshi

504 views
10:37

ASH 2022 Mezigdomide (CC-92480) + Dex in R/R MM: Preliminary Results…

ASH 2022 Conference Coverage

P. Richardson

178 views
10:37

ASH 2022 Subsequent Antimyeloma Therapies From ICARIA-MM Study: Pom/…

ASH 2022 Conference Coverage

P. Richardson

116 views
24:19

Phase 3 DETERMINATION Trial: RVd ± ASCT & Lenalidomide Maintenance t…

Dana-Farber Cancer Institute

P. Richardson

385 views
12:09

2022 Treatment Landscape and Future Directions of R/R Multiple Myelo…

Dana-Farber Cancer Institute

N. Munshi

459 views
08:51

EHA 2020 ICARIA-MM Data on Isatuximab in R/R Multiple Myeloma: Does …

Dana-Farber Cancer Institute

P. Richardson

247 views
06:23

EHA/ASH 2020 Update on mAbs for R/R Multiple Myeloma: Is the Additio…

Dana-Farber Cancer Institute

P. Richardson

169 views
19:38

Waldenström Macroglobulinemia - Standard Treatment Options and Revie…

Dana-Farber Cancer Institute

J. Castillo

257 views
12:07

Waldenström Macroglobulinemia: Diagnostic criteria, Why Not Treat Ev…

Dana-Farber Cancer Institute

J. Castillo

647 views
17:47

Relapse Refractory Myeloma and Novel Treatments

Dana-Farber Cancer Institute

N. S. Raje

246 views
16:28

Is it Time to Treat Patients with Smoldering Myeloma in 2018?

Dana-Farber Cancer Institute

I. Ghobrial

206 views
35:43

2016 Multiple Myeloma Patient Education Symposium: Novel Treatments …

Dana-Farber Cancer Institute

N. S. Raje

123 views